マイクロバイオーム診断市場：製品タイプ、用途、エンドユーザー別-2024-2030年の世界予測

マイクロバイオーム診断市場規模は2023年に7億9,936万米ドルと推定され、2024年には9億6,027万米ドルに達し、CAGR 20.72%で2030年には29億8,787万米ドルに達すると予測されています。

マイクロバイオーム診断は、特定の環境、特に人体内のマイクロバイオームの組成と機能を分析するために使用される高度な科学的プロセスと技術を指します。これらの診断法は、ハイスループット配列決定技術とバイオインフォマティクスツールを活用し、特に腸、皮膚、口腔などの特定の生息環境に共存する細菌、ウイルス、真菌、その他の微生物を含む多様な微生物を同定、分類、理解します。このセグメントは、これらの微生物と宿主との間の複雑な相互作用に光を当て、健康状態や疾病状態の理解に大きく貢献し、それによって新たな治療法や診断法の開発のための潜在的な道筋を提供することを目指しています。マイクロバイオーム診断は個別化医療において極めて重要な役割を担っており、個人固有のマイクロバイオーム組成に基づき、より正確で個別化された治療・予防戦略の創出を可能にしています。慢性疾患の有病率の上昇と、これらの疾患の診断におけるマイクロバイオームの重要な役割が、マイクロバイオーム診断法の採用を世界的に後押ししています。さらに、政府の取り組みや支援がこのセグメントの研究を大幅に後押しし、マイクロバイオーム診断市場をさらに前進させています。有望な成長にもかかわらず、マイクロバイオーム診断市場は払い戻し政策の欠如による課題に直面しており、こうした革新的な試験を患者が利用する妨げとなっています。しかし、微生物ベースの研究に対する投資の急増は、革新的な診断ツールの開発を促進し、市場の将来的な成長展望を作り出しています。

複雑な分析に対応できる正確で効率的な機器の必要性

マイクロバイオーム診断セグメントの機器は、マイクロバイオームサンプルの正確かつ精密な分析に不可欠です。これらの機器には、次世代シーケンサー（NGS）装置、質量分析計、定量PCR（qPCR）装置などが含まれます。これらの機器は、微生物の実体やその機能を同定・定量化するプロセスに不可欠であり、急速に発展するマイクロバイオーム診断のセグメントにおいて不可欠なツールとなっています。試薬とキットは、サンプル調製、処理、分析のためにマイクロバイオーム診断機器と共に使用される必須の消耗品です。これらの製品には、多種多様なDNAとRNA抽出キット、シーケンス用ライブラリー調製キット、PCR試薬、微生物培養培地などが含まれます。各製品は、微生物学的サンプルの同定と解析を効率的に行うためのワークフローを最適化するように設計されています。

個別化治療を開発する製薬・バイオテクノロジー企業におけるマイクロバイオーム診断の採用拡大

製薬会社やバイオテクノロジー企業は、マイクロバイオーム診断のエンドユーザーとして重要な位置を占めています。これらの企業は、革新的な治療ソリューション、個別化医療、次世代プロバイオティクスの開発にマイクロバイオームの知見を活用することに主眼を置いています。ヒトマイクロバイオームと様々な疾患との間の複雑な相互作用を理解することに強い関心を持ち、これらの企業はマイクロバイオーム診断を活用して、新薬対象の同定、薬効の強化、副作用の発生率の低減を図っています。研究・学術機関は、マイクロバイオームの多様性、機能、動態を探求する質の高い基礎研究の実施に注力しています。研究者や学術機関は、疾患の発症や健康維持、新たな治療戦略の開発におけるマイクロバイオームの役割について、新たな知見を見出すことができます。これらの研究機関から得られた知見は、トランスレーショナルリサーチやマイクロバイオームベースの製品の商業化への道を開くことが多いです。さらに、研究・学術機関は、革新的な医療ソリューションの開発におけるマイクロバイオーム研究の応用を促進するため、製薬会社やバイオテクノロジー会社を含む官民両部門と頻繁に連携しています。

地域別洞察

南北アメリカのマイクロバイオーム診断市場は、主に米国とカナダにおける研究開発活動の活発化によって大きな成長を遂げています。同地域の強力な医療インフラ、消化器疾患の高い有病率、マイクロバイオームバランスの重要性に対する意識の高まりが、同地域におけるマイクロバイオーム診断の採用を促進する主要要因となっています。欧州、中東、アフリカ地域では、欧州がマイクロバイオーム診断市場の主要な貢献国として際立っており、健康や病気におけるヒトマイクロバイオームの役割を理解することを目的とした政府や民間の数多くの研究イニシアチブに支えられています。中東・アフリカは有望な成長を見せており、これらの地域で流行している疾患とマイクロバイオームの関連性に焦点を当てた研究が増加しています。アジア太平洋は、医療インフラの急速な改善と中国、日本、韓国におけるマイクロバイオーム研究への投資の増加により、マイクロバイオーム診断市場で最も速い成長を示しています。さらに、患者数が多く、マイクロバイオーム試験に対する認識が高まっていることも、同地域におけるマイクロバイオーム診断のニーズを後押ししています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスはマイクロバイオーム診断市場の評価において極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を記載しています。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます。フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、マイクロバイオーム診断市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、このセグメントの競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています。

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を記載しています。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発とイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を記載しています。

本レポートは、以下のような主要な質問に対応しています。

1.マイクロバイオーム診断市場の市場規模と予測は？

2.マイクロバイオーム診断市場の予測期間中に投資を検討すべき製品、セグメント、用途、セグメントは何か？

3.マイクロバイオーム診断市場の技術動向と規制枠組みは？

4.マイクロバイオーム診断市場における主要ベンダーの市場シェアは？

5.マイクロバイオーム診断市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の有病率の上昇とマイクロバイオームに基づく診断の重要性
    • マイクロバイオーム調査に対する政府の取り組みと支援
  • 抑制要因
    • マイクロバイオームに基づく診断に対する償還政策の欠如
  • 機会
    • マイクロバイオームに基づく調査への投資増加
    • パーソナライズされた治療法の開発におけるマイクロバイオーム診断のポテンシャルの高まり
  • 課題
    • マイクロバイオームを対象とした標準化されたプロトコルと利用可能な治療法の欠如
• 市場セグメンテーション分析
  • 製品タイプ：複雑な分析に対応できる正確で効率的な機器の必要性
  • エンドユーザー：製薬企業やバイオテクノロジー企業におけるパーソナライズされた治療法の開発のためのマイクロバイオーム診断の採用が増加
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 マイクロバイオーム診断市場：製品タイプ別

• イントロダクション
• 機器
• 試薬とキット

第7章 マイクロバイオーム診断市場：用途別

• イントロダクション
• 胃腸障害
• 感染症
• 代謝障害

第8章 マイクロバイオーム診断市場：エンドユーザー別

• イントロダクション
• 製薬・バイオテクノロジー企業
• 研究・学術機関

第9章 南北アメリカのマイクロバイオーム診断市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋のマイクロバイオーム診断市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのマイクロバイオーム診断市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

第13章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. MICROBIOME DIAGNOSTICS MARKET RESEARCH PROCESS
• FIGURE 2. MICROBIOME DIAGNOSTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. MICROBIOME DIAGNOSTICS MARKET DYNAMICS
• FIGURE 7. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. MICROBIOME DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. MICROBIOME DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MICROBIOME DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 28. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 29. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 30. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 31. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 32. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 33. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 34. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 35. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 36. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 37. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 38. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 39. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 40. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 41. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 42. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 43. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 44. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 45. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 46. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 47. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 48. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 49. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 50. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 51. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 52. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 53. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 54. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 55. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 56. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 57. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 58. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 59. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 60. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 61. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 62. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 63. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 64. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 65. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 66. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 68. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 70. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 72. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 74. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 75. AUSTRALIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 76. AUSTRALIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 77. AUSTRALIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 78. AUSTRALIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 79. AUSTRALIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 80. AUSTRALIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 81. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 82. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 83. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 84. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 85. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 86. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 87. INDIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 88. INDIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 89. INDIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 90. INDIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 91. INDIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 92. INDIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 93. INDONESIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 94. INDONESIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 95. INDONESIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 96. INDONESIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 97. INDONESIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 98. INDONESIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 99. JAPAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 100. JAPAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 101. JAPAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 102. JAPAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 103. JAPAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 104. JAPAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 105. MALAYSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 106. MALAYSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 107. MALAYSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 108. MALAYSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 109. MALAYSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 110. MALAYSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 111. PHILIPPINES MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 112. PHILIPPINES MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 113. PHILIPPINES MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 114. PHILIPPINES MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 115. PHILIPPINES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 116. PHILIPPINES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 117. SINGAPORE MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 118. SINGAPORE MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 119. SINGAPORE MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 120. SINGAPORE MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 121. SINGAPORE MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 122. SINGAPORE MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 124. SOUTH KOREA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 126. SOUTH KOREA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 128. SOUTH KOREA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 129. TAIWAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 130. TAIWAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 131. TAIWAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 132. TAIWAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 133. TAIWAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 134. TAIWAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 135. THAILAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 136. THAILAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 137. THAILAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 138. THAILAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 139. THAILAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 140. THAILAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 141. VIETNAM MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 142. VIETNAM MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 143. VIETNAM MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 144. VIETNAM MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 145. VIETNAM MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 146. VIETNAM MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 155. DENMARK MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 156. DENMARK MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 157. DENMARK MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 158. DENMARK MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 159. DENMARK MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 160. DENMARK MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 161. EGYPT MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 162. EGYPT MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 163. EGYPT MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 164. EGYPT MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 165. EGYPT MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 166. EGYPT MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 167. FINLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 168. FINLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 169. FINLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 170. FINLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 171. FINLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 172. FINLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 173. FRANCE MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 174. FRANCE MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 175. FRANCE MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 176. FRANCE MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 177. FRANCE MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 178. FRANCE MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 179. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 180. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 181. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 182. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 183. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 184. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 185. ISRAEL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 186. ISRAEL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 187. ISRAEL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 188. ISRAEL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 189. ISRAEL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 190. ISRAEL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 191. ITALY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 192. ITALY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 193. ITALY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 194. ITALY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 195. ITALY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 196. ITALY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 197. NETHERLANDS MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 198. NETHERLANDS MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 199. NETHERLANDS MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 200. NETHERLANDS MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 201. NETHERLANDS MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 202. NETHERLANDS MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 203. NIGERIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 204. NIGERIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 205. NIGERIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 206. NIGERIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 207. NIGERIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 208. NIGERIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 209. NORWAY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 210. NORWAY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 211. NORWAY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 212. NORWAY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 213. NORWAY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 214. NORWAY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 215. POLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 216. POLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 217. POLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 218. POLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 219. POLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 220. POLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 221. QATAR MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 222. QATAR MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 223. QATAR MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 224. QATAR MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 225. QATAR MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 226. QATAR MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 227. RUSSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 228. RUSSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 229. RUSSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 230. RUSSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 231. RUSSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 232. RUSSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 234. SAUDI ARABIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 236. SAUDI ARABIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 238. SAUDI ARABIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 240. SOUTH AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 242. SOUTH AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 244. SOUTH AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 245. SPAIN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 246. SPAIN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 247. SPAIN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 248. SPAIN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 249. SPAIN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 250. SPAIN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 251. SWEDEN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 252. SWEDEN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 253. SWEDEN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 254. SWEDEN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 255. SWEDEN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 256. SWEDEN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 257. SWITZERLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 258. SWITZERLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 259. SWITZERLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 260. SWITZERLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 261. SWITZERLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 262. SWITZERLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 263. TURKEY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 264. TURKEY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 265. TURKEY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 266. TURKEY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 267. TURKEY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 268. TURKEY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 276. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 278. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 280. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 281. MICROBIOME DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 282. MICROBIOME DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

[197 Pages Report] The Microbiome Diagnostics Market size was estimated at USD 799.36 million in 2023 and expected to reach USD 960.27 million in 2024, at a CAGR 20.72% to reach USD 2,987.87 million by 2030.

Microbiome diagnostics refers to the advanced scientific process and technologies used to analyze the composition and function of the microbiomes within a specific environment, especially within the human body. These diagnostic methods leverage high-throughput sequencing technologies and bioinformatics tools to identify, categorize, and understand the diverse array of microorganisms, including bacteria, viruses, fungi, and other microbes, that coexist in particular habitats, notably the gut, skin, and oral cavities among others. This field aims to shed light on the complex interactions between these microorganisms and their host, contributing significantly to the understanding of health and disease states, thereby offering potential pathways for novel therapeutic and diagnostic developments. Microbiome diagnostics has a crucial role in personalized medicine, enabling the creation of more precise, individualized approaches to treatment and prevention strategies based on the unique microbiome compositions of individuals. The rising prevalence of chronic diseases and the critical role of the microbiome in diagnosing these conditions has driven the adoption of microbiome diagnostics methods globally. Additionally, government initiatives and support have substantially boosted research in this domain, further propelling the microbiome diagnostics market forward. Despite the promising growth, the microbiome diagnostics market faces challenges owing to the lack of reimbursement policies, which can hinder patient access to these innovative tests. However, the surge in investment for microbiome-based research is catalyzing the development of innovative diagnostics tools, creating a future growth landscape for the market.

Product Type: Need for accurate and efficient instruments capable of handling complex analyses

Instruments in the microbiome diagnostics field are crucial for the accurate and precise analysis of microbiome samples. These instruments include next-generation sequencing (NGS) machines, mass spectrometers, and quantitative PCR (qPCR) devices. These instruments are integral to the process of identifying and quantifying microbial entities and their functions, making them indispensable tools in the rapidly evolving field of microbiome diagnostics. Reagents and kits are essential consumables used alongside microbiome diagnostic instruments for sample preparation, processing, and analysis. These products include a wide variety of DNA and RNA extraction kits, library preparation kits for sequencing, PCR reagents, and microbial culture media, among others. Each is designed to optimize the workflow for identifying and analyzing microbiological samples efficiently.

End-user: Growing adoption of microbiome diagnostics in pharmaceutical and biotechnology companies to develop personalized therapies

Pharmaceutical and biotechnology companies are a significant segment of the end-users for microbiome diagnostics. These organizations are primarily focused on leveraging microbiome insights to develop innovative therapeutic solutions, personalized medicine, and next-generation probiotics. With a keen interest in understanding the complex interactions between the human microbiome and various diseases, these companies utilize microbiome diagnostics to identify new drug targets, enhance drug efficacy, and reduce the incidence of adverse reactions. Research & academic institutes focus on conducting high-quality, foundational research exploring the microbiome's diversity, function, and dynamics. Researchers and academics are able to uncover novel insights into the role of the microbiome in disease pathogenesis, health maintenance, and the development of new therapeutic strategies. The findings from these institutions often pave the way for translational research and the commercialization of microbiome-based products. Furthermore, research & academic Institutes frequently collaborate with both public and private sector entities, including pharmaceutical and biotechnology companies, to further the application of microbiome research in developing innovative healthcare solutions.

Regional Insights

The microbiome diagnostics market in the Americas is experiencing significant growth, primarily driven by increased research and development activities in the United States and Canada. The region's strong healthcare infrastructure, coupled with a high prevalence of gastrointestinal diseases and growing awareness about the importance of microbiome balance, are key factors driving the adoption of microbiome diagnostics in the region. In the EMEA region, Europe stands out as a major contributor to the microbiome diagnostics market, supported by numerous government and private research initiatives aimed at understanding the human microbiome's role in health and disease. The Middle East and Africa are showing promising growth, with an increasing number of studies focusing on the microbiome's link to prevalent diseases in these areas. Asia-Pacific is witnessing the fastest growth in the microbiome diagnostics market, owing to rapidly improving healthcare infrastructures and increasing investments in microbiome research in China, Japan, and South Korea. Moreover, a large patient pool and growing awareness about microbiome testing drive the need for microbiome diagnostics in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Microbiome Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Microbiome Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Microbiome Diagnostics Market, highlighting leading vendors and their innovative profiles. These include 4D Pharma PLC, AOBiome Therapeutics, Atlas Biomed, BioGaia, BIOHM Health, Bione Ventures Private Limited, DayTwo, DNA Genotek Inc. by OraSure Technologies Inc., Du Pont De Nemours and Co., Enterome, Evvy, Ferring Pharmaceuticals, Finch Therapeutics Group, Flightpath Biosciences, Inc., Genetic Analysis AS, Gnubiotics Sciences, International Flavors & Fragrances Inc, Luxia Scientific, MEtabiomics, Microba Life Sciences, OptiBiotix Health PLC, Osel Inc., Quantbiome, Inc., Rebiotix, Second Genome, Inc., Seed Health, Seres Therapeutics, Sun Genomics, Symbiotix Biotherapies,, Synlogic, Inc., Synthetic Biologics, Vedanta Biosciences, Inc., Viome Life Sciences, Inc., ViThera, ViThera Pharmaceuticals, Inc., Yakult Honsha Co., and YSOPIA Bioscience.

Market Segmentation & Coverage

This research report categorizes the Microbiome Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product Type
  • Instruments
  • Reagents & Kits

• Application
  • Gastrointestinal Disorders
  • Infectious Diseases
  • Metabolic Disorders

• End-user
  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Microbiome Diagnostics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Microbiome Diagnostics Market?

3. What are the technology trends and regulatory frameworks in the Microbiome Diagnostics Market?

4. What is the market share of the leading vendors in the Microbiome Diagnostics Market?

5. Which modes and strategic moves are suitable for entering the Microbiome Diagnostics Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of chronic diseases and significance of microbiome-based diagnostics
    • 5.1.1.2. Government initiatives and support for microbiome research
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of reimbursement policies for microbiome-based diagnostics
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing investment in microbiome-based research
    • 5.1.3.2. Growing potential of microbiome diagnostics in developing personalized treatments
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of standardized protocols and available therapeutics targeting the microbiome
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Need for accurate and efficient instruments capable of handling complex analyses
  • 5.2.2. End-user: Growing adoption of microbiome diagnostics in pharmaceutical and biotechnology companies to develop personalized therapies
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Microbiome Diagnostics Market, by Product Type

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Reagents & Kits

7. Microbiome Diagnostics Market, by Application

• 7.1. Introduction
• 7.2. Gastrointestinal Disorders
• 7.3. Infectious Diseases
• 7.4. Metabolic Disorders

8. Microbiome Diagnostics Market, by End-user

• 8.1. Introduction
• 8.2. Pharmaceutical & Biotechnology Companies
• 8.3. Research & Academic Institutes

9. Americas Microbiome Diagnostics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Microbiome Diagnostics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Microbiome Diagnostics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Launch of "Targeted Microbiome Profiling", a pathway-based microbiome profiling service for health and disease
  • 12.3.2. Evvy, Precision Women's Health Startup focused on the Vaginal Microbiome, Announces USD 14 million Series A
  • 12.3.3. Xume partners with Microbiome.in and TruDiagno to help people make gut microbiome-informed choices
• 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio